Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (pTNHL) of the elderly: Final results of 116 patients treated in the international ACT-2 phase III trial - Trumper, L H; Wulf, G; Ziepert, M (J Clin Oncol, 2016)
. doi:10.1200/JCO.2016.34.15_suppl.7500